Stock Market Analysis & Comment

DUK has outperformed peers over the past year. The company is well-positioned for long-term growth. Consensus outlook is bullish, with expected total return of 13% over next 12 months. The...

This article was written exclusively for Investing.comBack in 2019, there was an intriguing bull case for Kellogg (NYSE:K) stock. The stock had been struggling for some time, gaining just 7% total...

After losing more than a quarter of its value since its all-time high on Nov. 22, is it time to buy Microsoft?Long-term investors could do worse than the world's largest software company by revenue...

Healthcare stocks have been some of this year’s best performers Defensive, blue-chips with reasonable valuations and strong dividends tend to do well in a bear market Consider buying...

This article was written exclusively for Investing.com The speculative biotech industry endured its worst historical drawdown over the last 16 months A recent thrust off long-term support creates a...

During the past decade, a combination of moderate interest rates and a favorable macroeconomic environment sent growth stocks flying, casting a shadow over most value-focused, dividend-paying...

MCD has maintained earnings in the face of rising inflation Shares are expensive Consensus rating is bullish For tools, data, and content to help you make better investing decisions, try...

Are there any cannabis stocks considered a buy anymore?If you look at the major names—especially the large Canadian companies traded on major US exchanges—the answer can be summed up in...

For those who missed last week in the markets, these were the returns of the major stock indices (second column to the right):Source: Investing.com As we can see, U.S. indices returned between...

Shares of Pfizer are down over 12.5% since the start of 2022. Plan to spend cash generated from COVID-19 vaccine on M&As and share buybacks. Long-term investors may consider buying PFE stock at...

This article was written exclusively for Investing.comIt's exceptionally easy to make the bear case for Spotify (NYSE:SPOT) stock. Even with the shares off 54% year-to-date and 65% from their 2021...

Reports fiscal Q4 2022 results on Monday, June 27, after the close Revenue expectation: $12.09 billion EPS expectation: $1.07 The current economic environment doesn't seem conducive for sportswear...

Stocks on Wall Street rallied on Friday, with the benchmark S&P 500 scoring its biggest one-day gain—hitting 3,911.74, up 116.01 points, or 3.06%—since May 2020 as investors pared back...

Investors will get fresh guidance on the outlook for earnings from some of the largest US companies next week when they release their latest quarterly numbers amid speculations that higher interest...